ABOUT US

Inventing novel and innovative medicines for treatment of cardiorenal, pulmonary, Fibrotic, neuropsychiatric and neurodegenerative, diseases.

INVENT Pharmaceuticals is designing, inventing and developing new safer and highly effective medicines to help improve patients lives.

We design, discover and develop new medicines by applying out powerful precision drug design and discovery platform. INVENT Pharmaceuticals' approach integrates its drug design with target selection, medicinal chemistry and drug discovery, site specific precision deuterium substitution strategy, in vitro and in vivo pharmacology, and deep domain knowledge and expertise, capabilities and artificial intelligence.

Therapeutic Areas

Cardiovascular-Renal-Pulmonary-Metabolic (CVRPM)

  • Cardiopulmonary - Pulmonary Arterial Hypertension (PAH)

  • Cardiorenal - Chronic Kidney Disease (CKD)

  • Uncontrolled/Resistance Hypertension (u/rHTN)

  • Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

  • Alzheimer's Disease (AD)

  • Cognitive Impairment Associated with Schizophrenia (CIAS)

  • Neuropsychiatric disorders

Central Nervous System (CNS)

Fibrotic Diseases

  • Liver Fibrosis

  • Small-Intestine Neuroendocrine Tumors (SI-NET)

Our Commitment

We are committed to advancing transformative therapeutics through the integration of precision science, cutting-edge technology, and deep therapeutic expertise.

info@inventpharma.com

© 2026 INVENT Pharmaceuticals. All rights reserved.